Inovio Pharmaceuticals Inc (INO)
10.60
+0.48
(+4.74%)
USD |
NASDAQ |
Apr 26, 14:36
Inovio Pharmaceuticals Cash from Investing (TTM): 87.36M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 87.36M |
September 30, 2023 | 121.41M |
June 30, 2023 | 171.46M |
March 31, 2023 | 107.25M |
December 31, 2022 | 109.59M |
September 30, 2022 | 49.09M |
June 30, 2022 | 60.49M |
March 31, 2022 | 121.10M |
December 31, 2021 | -175.34M |
September 30, 2021 | -172.57M |
June 30, 2021 | -189.41M |
March 31, 2021 | -282.10M |
December 31, 2020 | -58.80M |
September 30, 2020 | -44.64M |
June 30, 2020 | -75.49M |
March 31, 2020 | -11.52M |
December 31, 2019 | -9.045M |
September 30, 2019 | -12.30M |
June 30, 2019 | -6.149M |
March 31, 2019 | -33.72M |
December 31, 2018 | 42.42M |
September 30, 2018 | 49.82M |
June 30, 2018 | -18.76M |
March 31, 2018 | -19.20M |
December 31, 2017 | -27.83M |
Date | Value |
---|---|
September 30, 2017 | -32.49M |
June 30, 2017 | 30.74M |
March 31, 2017 | 34.78M |
December 31, 2016 | 16.27M |
September 30, 2016 | -14.87M |
June 30, 2016 | -25.92M |
March 31, 2016 | -52.83M |
December 31, 2015 | -54.82M |
September 30, 2015 | -56.82M |
June 30, 2015 | -65.16M |
March 31, 2015 | -38.86M |
December 31, 2014 | -35.81M |
September 30, 2014 | -17.34M |
June 30, 2014 | -7.203M |
March 31, 2014 | -8.529M |
December 31, 2013 | -9.237M |
September 30, 2013 | -2.013M |
June 30, 2013 | 1.615M |
March 31, 2013 | 6.071M |
December 31, 2012 | 5.276M |
September 30, 2012 | -4.310M |
June 30, 2012 | -7.775M |
March 31, 2012 | -10.05M |
December 31, 2011 | -10.90M |
September 30, 2011 | -1.516M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-282.10M
Minimum
Mar 2021
171.46M
Maximum
Jun 2023
-11.03M
Average
-9.045M
Median
Dec 2019
Cash from Investing (TTM) Benchmarks
Cerus Corp | 8.624M |
Stereotaxis Inc | 19.76M |
Viemed Healthcare Inc | -52.11M |
AIM ImmunoTech Inc | -0.832M |
Protalix BioTherapeutics Inc | -16.71M |